×
About 29,290 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  12,983 results

Temporal trends of birthweight are not driving trends of atopic dermatitis prevalence i...
https://doi.org/10.1007/s00403-021-02188-0 10.1016/S0140-6736(06)69283-0 10.1067/mjd.2000.107773 10.1016/j.jaad.2017.12.015 10.11124/JBISRIR-2016-003177 10.1111/bjd.14031 10.1002/iid3.217 10.1080/1744666X.2016.1212660 10.1007/s10995-012-0960-8 10.1007/s11882-020-00971-z
Archives of Dermatological Research; Hou A, Silverberg JI

Jan 25th, 2021 - Population-based risk-factors for the rising prevalence of childhood atopic dermatitis (AD) in the United States are not well elucidated. We hypothesized that trends of birthweight over the past 2 decades contributed to the increasing prevalence o...

Improving patient education for atopic dermatitis: A randomized controlled trial of a c...
https://doi.org/10.1111/pde.14519
Pediatric Dermatology; LeBovidge JS, Timmons K et. al.

Jan 24th, 2021 - Patient education is important to families' ability to manage and cope with pediatric atopic dermatitis (AD). We evaluated whether an educational handbook could improve AD symptoms, caregiver confidence in AD management skills, and AD-related qual...

Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic E...
https://doi.org/10.1159/000512965
International Archives of Allergy and Immunology; Murata S, Kaneko S et. al.

Jan 24th, 2021 - The stratum corneum contains several growth factors and cytokines that are synthesized in keratinocytes. We previously reported that the amount of interleukin-8 in the stratum corneum (scIL-8) is related to the severity of local skin inflammation ...

Emerging Nanomedicines for the Treatment of Atopic Dermatitis.
https://doi.org/10.1208/s12249-021-01920-3 10.1007/BF00370717 10.1101/gad.813600 10.1590/abd1806-4841.20164211 10.1155/2014/354250 10.1016/j.sder.2012.07.002 10.1159/000370220 10.1016/j.jid.2017.02.196 10.1016/S0140-6736(20)31286-1 10.2500/aap.2012.33.3569 10.1016/S0140-6736(06)69283-0 10.1056/NEJMcp042803 10.1046/j.1525-1470.1998.1998015347.x 10.1016/j.jaci.2008.01.034 10.2500/aap2007.28.3041 10.1016/j.coi.2020.02.007 10.1111/all.12184 10.1038/ng1767 10.1111/j.1468-3083.2009.03327.x 10.1016/j.jaci.2006.04.042 10.1016/j.jaci.2008.01.022 10.1038/jid.2008.280 10.1111/j.1346-8138.2009.00662.x 10.1016/j.alit.2016.12.003 10.1172/JCI116711 10.1038/sj.jid.5701201 10.1046/j.1523-1747.2003.12128.x 10.1016/j.ejpb.2011.02.016 10.1542/peds.2007-1651 10.1111/j.1399-3038.2005.00372.x 10.1111/j.1529-8019.2006.00063.x 10.1016/j.jaci.2006.03.045 10.1111/j.1346-8138.2009.00706.x 10.1111/j.1346-8138.2008.00507.x 10.1016/j.sder.2012.07.006 10.4103/2229-5178.142483 10.1067/mjd.2003.58 10.2174/0929866521666140807114240 10.3109/1061186X.2012.716845 10.1016/0169-409X(91)90046-F 10.1016/j.drudis.2016.02.011 10.1007/s40005-018-00418-8 10.1016/j.carbpol.2018.06.023 10.1007/s13346-018-0480-1 10.1016/j.ejpb.2016.01.002 10.1007/s13346-017-0439-7 10.1016/j.ijpharm.2016.11.029 10.1016/0378-5173(89)90281-0 10.2147/IJN.S150319 10.3109/10837450.2012.712537 10.1016/j.ijpharm.2012.04.051 10.15171/apb.2015.043 10.1016/S0378-5173(02)00180-1 10.1016/j.jconrel.2017.08.033 10.34172/apb.2020.021 10.1016/j.ijpharm.2016.05.005 10.1016/j.ejpb.2012.11.026 10.1016/S0378-5173(99)00413-5 10.1016/j.ajps.2015.07.005 10.1016/j.ijpharm.2010.09.030 10.1016/j.ijpharm.2009.09.002 10.1007/s13346-012-0060-8 10.1186/s12951-017-0323-0 10.1016/j.ijpharm.2015.12.019 10.3390/pharmaceutics12050400 10.1080/21691401.2017.1408123 10.5012/bkcs.2011.32.3.956 10.1016/j.colsurfb.2009.09.033 10.1016/j.ejpb.2016.08.001 10.2174/1871523017666181115104159 10.1081/DDC-120001481 10.1007/s11095-005-8176-x 10.1016/j.jconrel.2004.11.020 10.3109/03639045.2013.819883 10.1016/j.ejpb.2012.02.008 10.1016/j.carbpol.2016.03.068 10.1016/j.ijpharm.2011.05.034 10.1016/j.ajps.2013.09.005 10.1039/b103275p 10.1021/jp044626d 10.1021/jp053396f 10.1016/j.ijpharm.2008.01.034 10.1016/j.ejps.2008.01.002 10.1016/j.ijpharm.2012.10.035 10.1016/j.jconrel.2016.09.003 10.4314/tjpr.v18i2.1 10.1021/mp400639e 10.1007/s13346-020-00743-2 10.1016/j.jconrel.2020.04.038 10.1016/j.jconrel.2020.07.021 10.1016/j.jconrel.2020.05.002
AAPS PharmSciTech; Parekh K, Mehta TA et. al.

Jan 24th, 2021 - Globally, the prevalence of Atopic dermatitis (AD) is significantly increasing and affecting around 20% of population including children. Complex interactions amongst abnormality in epidermal barrier function, environment, infectious agents and im...

Validity and reliability of Patient-Reported Outcomes Measurement Information System Gl...
https://doi.org/10.1016/j.jaad.2021.01.033
Journal of the American Academy of Dermatology; Schwartzman G, Lei D et. al.

Jan 23rd, 2021 - Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life (HRQOL) in several diseases. Little is known about its measurement properties in adult atopic dermatitis (AD). Exam...

see more →

Guidelines  35 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

see more →

Drugs  611 results see all →

Clinicaltrials.gov  14,155 results

Temporal trends of birthweight are not driving trends of atopic dermatitis prevalence i...
https://doi.org/10.1007/s00403-021-02188-0 10.1016/S0140-6736(06)69283-0 10.1067/mjd.2000.107773 10.1016/j.jaad.2017.12.015 10.11124/JBISRIR-2016-003177 10.1111/bjd.14031 10.1002/iid3.217 10.1080/1744666X.2016.1212660 10.1007/s10995-012-0960-8 10.1007/s11882-020-00971-z
Archives of Dermatological Research; Hou A, Silverberg JI

Jan 25th, 2021 - Population-based risk-factors for the rising prevalence of childhood atopic dermatitis (AD) in the United States are not well elucidated. We hypothesized that trends of birthweight over the past 2 decades contributed to the increasing prevalence o...

Improving patient education for atopic dermatitis: A randomized controlled trial of a c...
https://doi.org/10.1111/pde.14519
Pediatric Dermatology; LeBovidge JS, Timmons K et. al.

Jan 24th, 2021 - Patient education is important to families' ability to manage and cope with pediatric atopic dermatitis (AD). We evaluated whether an educational handbook could improve AD symptoms, caregiver confidence in AD management skills, and AD-related qual...

Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic E...
https://doi.org/10.1159/000512965
International Archives of Allergy and Immunology; Murata S, Kaneko S et. al.

Jan 24th, 2021 - The stratum corneum contains several growth factors and cytokines that are synthesized in keratinocytes. We previously reported that the amount of interleukin-8 in the stratum corneum (scIL-8) is related to the severity of local skin inflammation ...

Emerging Nanomedicines for the Treatment of Atopic Dermatitis.
https://doi.org/10.1208/s12249-021-01920-3 10.1007/BF00370717 10.1101/gad.813600 10.1590/abd1806-4841.20164211 10.1155/2014/354250 10.1016/j.sder.2012.07.002 10.1159/000370220 10.1016/j.jid.2017.02.196 10.1016/S0140-6736(20)31286-1 10.2500/aap.2012.33.3569 10.1016/S0140-6736(06)69283-0 10.1056/NEJMcp042803 10.1046/j.1525-1470.1998.1998015347.x 10.1016/j.jaci.2008.01.034 10.2500/aap2007.28.3041 10.1016/j.coi.2020.02.007 10.1111/all.12184 10.1038/ng1767 10.1111/j.1468-3083.2009.03327.x 10.1016/j.jaci.2006.04.042 10.1016/j.jaci.2008.01.022 10.1038/jid.2008.280 10.1111/j.1346-8138.2009.00662.x 10.1016/j.alit.2016.12.003 10.1172/JCI116711 10.1038/sj.jid.5701201 10.1046/j.1523-1747.2003.12128.x 10.1016/j.ejpb.2011.02.016 10.1542/peds.2007-1651 10.1111/j.1399-3038.2005.00372.x 10.1111/j.1529-8019.2006.00063.x 10.1016/j.jaci.2006.03.045 10.1111/j.1346-8138.2009.00706.x 10.1111/j.1346-8138.2008.00507.x 10.1016/j.sder.2012.07.006 10.4103/2229-5178.142483 10.1067/mjd.2003.58 10.2174/0929866521666140807114240 10.3109/1061186X.2012.716845 10.1016/0169-409X(91)90046-F 10.1016/j.drudis.2016.02.011 10.1007/s40005-018-00418-8 10.1016/j.carbpol.2018.06.023 10.1007/s13346-018-0480-1 10.1016/j.ejpb.2016.01.002 10.1007/s13346-017-0439-7 10.1016/j.ijpharm.2016.11.029 10.1016/0378-5173(89)90281-0 10.2147/IJN.S150319 10.3109/10837450.2012.712537 10.1016/j.ijpharm.2012.04.051 10.15171/apb.2015.043 10.1016/S0378-5173(02)00180-1 10.1016/j.jconrel.2017.08.033 10.34172/apb.2020.021 10.1016/j.ijpharm.2016.05.005 10.1016/j.ejpb.2012.11.026 10.1016/S0378-5173(99)00413-5 10.1016/j.ajps.2015.07.005 10.1016/j.ijpharm.2010.09.030 10.1016/j.ijpharm.2009.09.002 10.1007/s13346-012-0060-8 10.1186/s12951-017-0323-0 10.1016/j.ijpharm.2015.12.019 10.3390/pharmaceutics12050400 10.1080/21691401.2017.1408123 10.5012/bkcs.2011.32.3.956 10.1016/j.colsurfb.2009.09.033 10.1016/j.ejpb.2016.08.001 10.2174/1871523017666181115104159 10.1081/DDC-120001481 10.1007/s11095-005-8176-x 10.1016/j.jconrel.2004.11.020 10.3109/03639045.2013.819883 10.1016/j.ejpb.2012.02.008 10.1016/j.carbpol.2016.03.068 10.1016/j.ijpharm.2011.05.034 10.1016/j.ajps.2013.09.005 10.1039/b103275p 10.1021/jp044626d 10.1021/jp053396f 10.1016/j.ijpharm.2008.01.034 10.1016/j.ejps.2008.01.002 10.1016/j.ijpharm.2012.10.035 10.1016/j.jconrel.2016.09.003 10.4314/tjpr.v18i2.1 10.1021/mp400639e 10.1007/s13346-020-00743-2 10.1016/j.jconrel.2020.04.038 10.1016/j.jconrel.2020.07.021 10.1016/j.jconrel.2020.05.002
AAPS PharmSciTech; Parekh K, Mehta TA et. al.

Jan 24th, 2021 - Globally, the prevalence of Atopic dermatitis (AD) is significantly increasing and affecting around 20% of population including children. Complex interactions amongst abnormality in epidermal barrier function, environment, infectious agents and im...

Validity and reliability of Patient-Reported Outcomes Measurement Information System Gl...
https://doi.org/10.1016/j.jaad.2021.01.033
Journal of the American Academy of Dermatology; Schwartzman G, Lei D et. al.

Jan 23rd, 2021 - Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life (HRQOL) in several diseases. Little is known about its measurement properties in adult atopic dermatitis (AD). Exam...

see more →

News  1,477 results

Fast Five Quiz: Atopic Dermatitis
https://reference.medscape.com/viewarticle/922925

Jan 21st, 2021 - Atopic dermatitis (AD), or atopic eczema, is a chronic inflammatory skin disorder that commonly presents as pruritic, ill-defined, dry patches with excoriations. AD can affect any part of the body. Up to 14% of adults may be affected by AD, with s...

Baseline Body Surface Area May Drive Optimal Baricitinib Response
https://www.medscape.com/viewarticle/943890

Jan 10th, 2021 - Patients with moderate to severe atopic dermatitis (AD) affecting between 10% and 50% of their body surface area (BSA) account for the majority of responders to baricitinib 2 mg, results from an analysis of phase 3 data showed. "This proposed clin...

Dupilumab Curbed Itch Intensity, Frequency in Children With Severe Eczema
https://www.medscape.com/viewarticle/943807

Jan 7th, 2021 - Dupilumab treatment with concomitant topical corticosteroids provided rapid and sustained improvement in itch intensity and frequency in children aged 6-11 years with severe atopic dermatitis. Dr Gil Yosipovitch The findings come from a post hoc a...

Swedish Registry Study Finds Atopic Dermatitis Significantly Associated With Autoimmune Diseases
https://www.medscape.com/viewarticle/943589

Jan 4th, 2021 - A diagnosis of atopic dermatitis in individuals ages 15 years or older, compared with controls without atopic dermatitis, was nearly twice as likely to be associated with autoimmune disease, in a case control study derived from Swedish national he...

Antihistamine Prescribing for AD Varies by Specialty
https://www.medscape.com/viewarticle/942699

Dec 14th, 2020 - Dermatologists are more likely than are nondermatologists to follow practice guidelines when prescribing antihistamines to treat pruritus associated with atopic dermatitis (AD), according to an analysis of a national database.   The American Acade...

see more →

Patient Education  29 results see all →